COVID-19 and the Nervous System

Overview

Journal J Neurovirol

Publisher Springer

Specialties Microbiology
Neurology

Date 2020 May 25

PMID 32447630

Citations 101

Authors

Joseph R Berger

Affiliations

Soon will be listed here.

Abstract

A pandemic due to novel coronavirus arose in mid-December 2019 in Wuhan, China, and in 3 months' time swept the world. The disease has been referred to as COVID-19, and the causative agent has been labelled SARS-CoV-2 due to its genetic similarities to the virus (SARS-CoV-1) responsible for the severe acute respiratory syndrome (SARS) epidemic nearly 20 years earlier. The spike proteins of both viruses dictate tissue tropism using the angiotensin-converting enzyme type 2 (ACE-2) receptor to bind to cells. The ACE-2 receptor can be found in nervous system tissue and endothelial cells among the tissues of many other organs.Neurological complications have been observed with COVID-19. Myalgia and headache are relatively common, but serious neurological disease appears to be rare. No part of the neuraxis is spared. The neurological disorders occurring with COVID-19 may have many pathophysiological underpinnings. Some appear to be the consequence of direct viral invasion of the nervous system tissue, others arise as a postviral autoimmune process, and still others are the result of metabolic and systemic complications due to the associated critical illness. This review addresses the preliminary observations regarding the neurological disorders reported with COVID-19 to date and describes some of the disorders that are anticipated from prior experience with similar coronaviruses.

Citing Articles

Retrospective Cohort Study: Severe COVID-19 Leads to Permanent Blunted Heart Rate Turbulence.

Yilmaz M, Mirzaoglu C Diagnostics (Basel). 2025; 15(5).

PMID: 40075869 PMC: 11899457. DOI: 10.3390/diagnostics15050621.

Exploring Symptom Overlaps: Post-COVID-19 Neurological Syndrome and Post-Concussion Syndrome in Athletes.

Mavroudis I, Petridis F, Petroaie A, Ciobica A, Kamal F, Honceriu C Biomedicines. 2024; 12(7).

PMID: 39062160 PMC: 11274969. DOI: 10.3390/biomedicines12071587.

COVID-19: Unveiling the Neuropsychiatric Maze-From Acute to Long-Term Manifestations.

Ariza D, Castellar-Visbal L, Marquina M, Rivera-Porras D, Galban N, Santeliz R Biomedicines. 2024; 12(6).

PMID: 38927354 PMC: 11200893. DOI: 10.3390/biomedicines12061147.

[Neurological complications in critical patients with COVID-19].

Abenza-Abildua M, Ramirez-Prieto M, Moreno-Zabaleta R, Arenas-Valls N, Salvador-Maya M, Algarra-Lucas C Neurologia. 2024; 35(9):621-627.

PMID: 38620654 PMC: 7402100. DOI: 10.1016/j.nrl.2020.07.014.

Impact of COVID-19 on football attacking players' match technical performance: a longitudinal study.

Luo L, Sun G, Guo E, Xu H, Wang Z Sci Rep. 2024; 14(1):6057.

PMID: 38480764 PMC: 10937722. DOI: 10.1038/s41598-024-56678-y.

References

Lau K, Yu W, Chu C, Lau S, Sheng B, Yuen K . Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004; 10(2):342-4. PMC: 3322928. DOI: 10.3201/eid1002.030638. View

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

Li F . Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016; 3(1):237-261. PMC: 5457962. DOI: 10.1146/annurev-virology-110615-042301. View

Yeh E, Collins A, Cohen M, Duffner P, Faden H . Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004; 113(1 Pt 1):e73-6. DOI: 10.1542/peds.113.1.e73. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P . Guillain-Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report. SAGE Open Med Case Rep. 2019; 7:2050313X19838750. PMC: 6429638. DOI: 10.1177/2050313X19838750. View

Seiden A . Postviral olfactory loss. Otolaryngol Clin North Am. 2004; 37(6):1159-66. DOI: 10.1016/j.otc.2004.06.007. View

Wang Y, Wang Y, Chen Y, Qin Q . Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020; 92(6):568-576. PMC: 7228347. DOI: 10.1002/jmv.25748. View

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

10.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

11.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

12.

Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

13.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

14.

Hwang C . Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006; 15(1):26-8. View

15.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View

16.

Netland J, Meyerholz D, Moore S, Cassell M, Perlman S . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008; 82(15):7264-75. PMC: 2493326. DOI: 10.1128/JVI.00737-08. View

17.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

18.

Hung E, Chim S, Chan P, Tong Y, Ng E, Chiu R . Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003; 49(12):2108-9. PMC: 7108123. DOI: 10.1373/clinchem.2003.025437. View

19.

Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

20.

Filatov A, Sharma P, Hindi F, Espinosa P . Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020; 12(3):e7352. PMC: 7170017. DOI: 10.7759/cureus.7352. View